Harnessing natural killer T (NKT) cells in human myeloma: progress and challenges.

Harnessing natural killer T (NKT) cells in human myeloma: progress and challenges.
复制标题

DOI:
10.1016/j.clim.2010.12.010
复制
发表时间:
2011-08
期刊:
Clinical immunology (Orlando, Fla.)
影响因子:
--
通讯作者:
Richter J
Richter J
中科院分区:
其他
文献类型:
--
作者:
Dhodapkar MV;Richter J

文献摘要

参考文献

被引文献

相似文献

多发性骨髓瘤是一种以骨髓中恶性浆细胞生长为特征的血液系统恶性肿瘤。骨髓瘤中的肿瘤细胞表达CD1d,并对CD1d限制性自然杀伤T细胞(NKT)的溶解敏感。在这里,我们讨论最近的研究,以利用这些细胞的性质在人类骨髓瘤的背景下。尽管有大量的临床前数据,但在临床上充分利用这些细胞的特性的尝试仍处于早期阶段。早期临床研究证明,在骨髓瘤患者体内,人类单核细胞来源的树突状细胞具有扩增NKT细胞的能力。这些结果为正在进行的将NKT激活与免疫调节药物相结合的研究奠定了基础。从这些研究中吸取的经验教训可能会为人类NKT疗法在其他环境中的最佳应用提供参考。
Multiple myeloma is a hematologic malignancy characterized by growth of malignant plasma cells in the bone marrow. Tumor cells in myeloma express CD1d and are sensitive to lysis by CD1d restricted natural killer T (NKT) cells. Here we discuss recent studies to harness the properties of these cells in the context of human myeloma. In spite of large body of preclinical data, attempts to fully harness the properties of these cells in the clinic are in early stages. Early phase clinical studies document the capacity of human monocyte-derived dendritic cells to expand NKT cells in vivo in myeloma patients. These results have set the stage for ongoing studies combining NKT activation with immune-modulatory drugs. Lessons learnt from these studies may inform the optimal application of human NKT based therapies in other settings as well.
DOI: 10.1016/s0022-1759(02)00497-0
发表时间: 2003-01-15
影响因子: 2.2
作者:
Fujii, S;Shimizu, K;Dhodapkar, MV
通讯作者: Dhodapkar, MV
DOI: 10.1038/leu.2009.279
发表时间: 2010-03-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Chan, A. C.;Neeson, P.;Berzins, S. P.
通讯作者: Berzins, S. P.
DOI: 10.1073/pnas.0802968105
发表时间: 2008-06-17
影响因子: 11.1
作者:
Barral, Patricia;Eckl-Dorna, Julia;Batista, Facundo D.
通讯作者: Batista, Facundo D.
DOI: 10.1084/jem.20042592
发表时间: 2005-05-02
期刊: The Journal of experimental medicine
影响因子: --
作者:
Chang DH;Osman K;Connolly J;Kukreja A;Krasovsky J;Pack M;Hutchinson A;Geller M;Liu N;Annable R;Shay J;Kirchhoff K;Nishi N;Ando Y;Hayashi K;Hassoun H;Steinman RM;Dhodapkar MV
通讯作者: Dhodapkar MV
DOI: 10.1038/ni827
发表时间: 2002-09-01
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者:
Fujii, S;Shimizu, K;Steinman, RM
通讯作者: Steinman, RM